Brief: Amgen Outlook FY Adjusted EPS USD 21.6-23
03/02/2026 21:01
Feb 03 (Reuters) - Amgen outlook FY capex USD 2,600 million.
Recent news on Amgen
See all newsFactbox: Global drugmakers invest billions to boost US presence
China's Harbour BioMed to focus on another patent case after $20 million damages award
Amgen owes $20.2 million in antibody patent lawsuit, US jury says (updated)
Amgen owes $20.2 mln in antibody patent lawsuit, US jury says
Amgen taps research firm to reassess Tavneos data (updated)